Skip to main content

Table 2 Observed and net survival rates (% (95% CI)) by histological types among lung cancers diagnosed in 2004 and recruited in 10 French cancer registries

From: Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries

 

Adenocarcinoma

N = 646

Squamous cell carcinoma

N = 524

Small cell carcinoma

N = 233

Number of person-years

1374.5

1020.7

264.8

Percentage of dead within 8 years

88.5%

88.7%

96.6%

Lost to follow-up at 8 years

1.4%

1.3%

0.4%

1-year survival rate

 Observed

49.4% (45.5–53.2%)

43.3% (39.0–47.5%)

31.8% (25.9–37.8%)

 Net

50.1% (46.2–54.0%)

44.5% (40.1–48.8%)

32.2% (26.2–38.3%)

5-year survival rate

 Observed

15.8% (13.1–18.8%)

14.9% (12.0–18.1%)

3.9% (1.9–6.9%)

 Net

17.1% (14.1–20.2%)

16.5% (13.1–19.9%)

4.1% (1.6–6.7%)

8-year survival rate

 Observed

11.2% (8.9–13.8%)

11.2% (8.7–14.1%)

3.4% (1.6–6.4%)

 Net

12.6% (9.8–15.4%)

13.4% (10.1–16.7%)

3.7% (1.1–6.3%)